【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Chronic Plaque Psoriasis Overview 8
Therapeutics Development 9
Pipeline Products for Chronic Plaque Psoriasis – Overview 9
Pipeline Products for Chronic Plaque Psoriasis – Comparative Analysis 10
Chronic Plaque Psoriasis – Therapeutics under Development by Companies 11
Chronic Plaque Psoriasis – Pipeline Products Glance 13
Late Stage Products 13
Clinical Stage Products 14
Chronic Plaque Psoriasis – Products under Development by Companies 15
Chronic Plaque Psoriasis – Companies Involved in Therapeutics Development 16
AbGenomics International, Inc. 16
Actelion Ltd 17
Almirall, S.A. 18
ApoPharma Inc. 19
Biotest AG 20
Boehringer Ingelheim GmbH 21
Can-Fite BioPharma Ltd. 22
Coherus BioSciences, Inc. 23
Covagen AG 24
Eli Lilly and Company 25
GlaxoSmithKline plc 26
Mitsubishi Tanabe Pharma Corporation 27
Novartis AG 28
OPKO Health, Inc. 29
Pfizer Inc. 30
Sandoz Inc. 31
Sun Pharmaceutical Industries Inc. 32
Takeda Pharmaceutical Company Limited 33
UCB S.A. 34
XenoPort, Inc. 35
Chronic Plaque Psoriasis – Therapeutics Assessment 36
Assessment by Monotherapy Products 36
Assessment by Target 37
Assessment by Mechanism of Action 39
Assessment by Route of Administration 41
Assessment by Molecule Type 43
Drug Profiles 45
AbGn-168H – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
adalimumab biosimilar – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
baricitinib – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
BI-655066 – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
certolizumab pegol – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
CF-101 – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
CJM-112 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
COVA-322 – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
dimethyl fumarate – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
etanercept biosimilar – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
etanercept biosimilar – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
GSK-2831781 – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
ixekizumab – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
lunacalcipol – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
MT-1303 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
namilumab – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
orilotimod – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
PF-06263276 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
ponesimod – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
tildrakizumab – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
tregalizumab – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
XP-23829 – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
Chronic Plaque Psoriasis – Recent Pipeline Updates 80
Chronic Plaque Psoriasis – Dormant Projects 102
Chronic Plaque Psoriasis – Discontinued Products 103
Chronic Plaque Psoriasis – Product Development Milestones 104
Featured News & Press Releases 104
Jul 16, 2014: Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis 104
Mar 28, 2012: Lilly’s Ixekizumab Met Primary Endpoint In Phase II Study In Patients With Chronic Plaque Psoriasis 104
Nov 24, 2011: Biotest Announces Completion Of Phase IIa Trial Of Tregalizumab In Chronic Plaque Psoriasis 106
Appendix 108
Methodology 108
Coverage 108
Secondary Research 108
Primary Research 108
Expert Panel Validation 108
Contact Us 109
Disclaimer 109
【レポート販売概要】
■ タイトル：慢性尋常性乾癬(Chronic Plaque Psoriasis)の治療薬パイプライン動向（2015年上半期版）■ 英文：Chronic Plaque Psoriasis - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6048IDB
■ 調査対象地域：グローバル
- cPDMの世界市場2016-2020About cPDM cPDM is software that is used to manage and integrate product data into a centralized system for better tracking and enhanced collaboration among business units. cPDM software solutions help enterprises streamline manufacturing and production processes by applying a consistent set of business solutions that collaboratively provide efficient methods to manage the functions of product lif …
- 炭素繊維強化プラスチック（CFRP）複合材料の世界市場2016-2026Visiongain’s new 272 page report assesses that the global carbon fibre reinforced plastic (CFRP) market will reach $29.08 billion in 2016. Are you involved in the Carbon Fibre Reinforced Plastic Market or need to understand its market dynamics? If so, then you must read this report It’s vital that you keep your knowledge up to date. You need this report. Market scope: This brand new report from vi …
- 組織アブレーションの世界市場2017-2021About Tissue Ablation Tissue ablation is a minimally invasive (MI), image-guided treatment modality used to treat, modify, or destroy cells (that are cancerous). In this process, a specifically equipped needle (probe) is inserted near the site of the tissue under study, and is guided by computed tomography (CT). Once the probe is in place, electricity (RFA), radio waves (microwave ablation), or li …
- 石油・ガス市場の契約動向：Saipems’ Awards Lifts Upstream SectorMonthly Oil & Gas Industry Contracts Review: Saipems’ Awards Lifts Upstream Sector Summary GlobalData's “Monthly Oil & Gas Industry Contracts Review: Saipems’ Awards Lifts Upstream Sector". The report is an essential source of data on the contracts and open tenders in the oil and gas industry. The report portrays detailed comparative data on the number of contracts and their value in the month, su …
- 石油・ガス産業用フレキシブルパイプの世界市場2016-2020About Flexible Pipes Flexible pipes are dynamic risers that are connected to subsea production equipment in topside facilities, which permit the flow of oil, gas, and water through them. Flexible pipes are also used on the seabed to tie wells and subsea equipment together. These pipes are largely used in the oil and gas industry, as they have an intrinsic property to reversibly soften on heating a …
- 中東の石油・ガスパイプライン産業見通しOil and Gas Pipelines Industry Outlook in Middle East to 2020 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Pipelines Summary "Oil and Gas Pipelines Industry Outlook in Middle East to 2020 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Pipelines" is a comprehensive report on major, trunk oil and gas pipelines industry …
- 頭蓋内圧（ICP）モニタリング装置の世界市場分析：方法別（侵襲的、非侵襲的）、用途別（外傷性脳傷害、脳内出血、髄膜炎、くも膜下出血、その他）、セグメント予測、2014-2025The global intracranial pressure monitoring devices market is expected to reach USD 1.9 billion 2025, according to a new report by Grand View Research, Inc. Increasing neurological disorders and growing awareness regarding various treatment options available is spurring the growth of these devices on a global level. In addition, constant rise in patient numbers suffering from severe brain diseases …
- 移植片対宿主病の疫学予測（～2023）EpiCast Report: Graft-Versus-Host Disease - Epidemiology Forecast to 2023 Summary Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either acute GVHD (aGVHD) or chronic GVHD (cGVHD). Both …
- 腹腔鏡装置の世界市場2019-2023127 pages, November 2018 About this market The increasing popularity of minimally invasive procedures in the healthcare sector had led the laparoscopic devices industry grow during our forecasted period. The leading healthcare providers are encouraging the shift from conventional open surgeries towards MI surgeries, as these are less painful and allow faster recovery for the patients to return hom …
- 高性能フィルムの世界市場2015-2022According to Stratistics MRC, the High Performance Films Market accounted for $28.34 billion in 2015 and is expected to reach $49.56 billion by 2022 growing at a CAGR of 8.3% from 2015 to 2022. Rising technological advancements in field of high performance films is one of the key factors fueling the market growth. However, factors such as huge capital cost and high level of technical competency ar …
- Victoria Oil & Gas plc：石油・ガスの開発・生産動向及びコスト分析– 2012Victoria Oil & Gas plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Victoria Oil & Gas plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- 医療ビジネスインテリジェンス(BI)のグローバル市場動向（～2018）The global healthcare BI market is mainly categorized by function, application, technology, end user, and geography. Cloud BI and mobile BI are expected to register highest growth rate among the healthcare BI market by technology during the forecast period.Their favorable growth is attributed to the increasing shift of healthcare organizations towards cloud computing models, increasing use of smar …
- 気道陽圧機器（PAP）の世界市場2016-2020About Positive Airway Pressure Devices Positive airway pressure (PAP) devices are used in intensive care units (ICUs), coronary care units (CCUs), operating rooms, and emergency wards of hospitals. PAP devices are pre-dosed pressure delivery systems that ensure upper airway pressure flow to keep the airways open during the treatment of obstructive sleep apnea (OSA). Congestive heart failure, sleep …
- 重症筋無力症(Myasthenia Gravis)の治療薬パイプライン動向（2015年上半期版）Myasthenia Gravis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Myasthenia Gravis - Pipeline Review, H1 2015’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism …
- 世界のオキソアルコール市場2015The Global Oxo Alcohol Industry Report 2015 is a professional and in-depth study on the current state of the Oxo Alcohol industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Oxo Alcohol market analysis is provided for the international markets including development trends, competitive landscape analysi …
